| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10072278 | American Journal of Ophthalmology | 2005 | 6 Pages |
Abstract
Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Andrew G. MD, Misha MD, Julie MD, Tammy COPT, Michael MD, Randy H. PhD, MD,